We provide 1 form of Cilostazol
Cilostazol
73963-72-1
|
369.216
|
3.528
Cilostazol and several of its metabolites are cyclic AMP phosphodiesterase III inhibitors, inhibiting phosphodiesterase activity and suppressing cAMP degradation with a resultant increase in cAMP in platelets and blood vessels, leading to inhibition of platelet aggregation and vasodilation. Cilostazol is indicated for the alleviation of symptoms of intermittent claudication.
Cilostazol
Cilostazol and several of its metabolites are cyclic AMP phosphodiesterase III inhibitors, inhibiting phosphodiesterase activity and suppressing cAMP degradation with a resultant increase in cAMP in platelets and blood vessels, leading to inhibition of platelet aggregation and vasodilation. Cilostazol is indicated for the alleviation of symptoms of intermittent claudication.
Cilostazol
$53/5 mg
(EBC)
1
We provide 2 compounds for Cilostazol
Cilostazol Related Compound A
6-hydroxy-1,2,3,4-tetrahydroquinolin-2-one
3,4-dihydro-6-hydroxy-2(1H)-quinolinone
54197-66-9
163.063
0.629
$19/5 mg
(EBC)
1
Cilostazol Related Compound C
6-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butyl]-1,2,3,4-tetrahydroquinolin-2-one
-
865792-18-3
575.37
5.595
$150/5 mg
(EBC)
1